158 related articles for article (PubMed ID: 9307257)
1. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.
Buée-Scherrer V; Buée L; Leveugle B; Perl DP; Vermersch P; Hof PR; Delacourte A
Ann Neurol; 1997 Sep; 42(3):356-9. PubMed ID: 9307257
[TBL] [Abstract][Full Text] [Related]
2. [An autopsy case of postencephalitic parkinsonism: investigation on neurofibrillary tangles in comparison with those in progressive supranuclear palsy].
Mori H; Yoshimura M; Mizutani T; Kuzuhara S; Yamanouchi H; Shimada H; Tomonaga M
No To Shinkei; 1990 Jun; 42(6):553-9. PubMed ID: 2169789
[TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative disorders with extensive tau pathology: a comparative study and review.
Feany MB; Dickson DW
Ann Neurol; 1996 Aug; 40(2):139-48. PubMed ID: 8773594
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
Buée-Scherrer V; Buée L; Hof PR; Leveugle B; Gilles C; Loerzel AJ; Perl DP; Delacourte A
Am J Pathol; 1995 Apr; 146(4):924-32. PubMed ID: 7717459
[TBL] [Abstract][Full Text] [Related]
6. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
[TBL] [Abstract][Full Text] [Related]
7. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
Halliday GM; Macdonald V; Henderson JM
Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of glial fibrillary tangles in progressive supranuclear palsy and Alzheimer's disease].
Nishimura M
No To Shinkei; 1996 Oct; 48(10):895-903. PubMed ID: 8921528
[No Abstract] [Full Text] [Related]
9. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
11. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
Joachim CL; Morris JH; Kosik KS; Selkoe DJ
Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
[TBL] [Abstract][Full Text] [Related]
12. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
13. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
[TBL] [Abstract][Full Text] [Related]
14. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
15. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
17. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
[TBL] [Abstract][Full Text] [Related]
19. Tau gene mutations and their effects.
Goedert M
Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic parkinsonism.
Yen SH; Horoupian DS; Terry RD
Ann Neurol; 1983 Feb; 13(2):172-5. PubMed ID: 6187274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
